| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/27/2008 | WO2008143533A1 Prognosis prediction for melanoma cancer |
| 11/27/2008 | WO2008143504A2 Parthenocarpic genetic elements derived from s. habrochaites |
| 11/27/2008 | WO2008143400A1 Animal models carrying tumors expressing human liver cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the above |
| 11/27/2008 | WO2008143192A1 Identification of transporter in charge of chemical transmission of aspartic acid and application thereof |
| 11/27/2008 | WO2008143177A1 Aquatic organism sampling apparatus and method of sampling aquatic organism |
| 11/27/2008 | WO2008143159A1 Method and kit for measurement of cholesterol in low-density lipoprotein |
| 11/27/2008 | WO2008143127A1 Method of measuring the activity of lipid-modified enzyme |
| 11/27/2008 | WO2008142888A1 Method of detecting cerebral stroke or asymptomatic cerebral infarction using acrolein, interleukin-6 and crp contents, polyamine oxidase activity or polyamine oxidase protein content and subject's age as indications |
| 11/27/2008 | WO2008142691A2 Method of removing support structure from 3-d objects made by solid freeform fabrication |
| 11/27/2008 | WO2008142571A2 Probe for detecting a particular nucleic acid sequence |
| 11/27/2008 | WO2008142567A2 Microrna molecules associated with inflammatory skin disorders |
| 11/27/2008 | WO2008142521A2 Functional assay to investigate unclassified sequence variants of mismatch repair genes |
| 11/27/2008 | WO2008142194A1 Method for the in vitro diagnosis/prognosis of huntington's chorea |
| 11/27/2008 | WO2008141561A1 System substitute pcr |
| 11/27/2008 | WO2008141514A1 System substitute pcr |
| 11/27/2008 | WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof |
| 11/27/2008 | WO2008141437A1 Reaction vessel with integrated optical and fluid control elements |
| 11/27/2008 | WO2008141436A1 Method for the detection and/or detoxification of compounds |
| 11/27/2008 | WO2008141392A1 Use of a bioassay to validate efficacy |
| 11/27/2008 | WO2008121911A3 Software for design and verification of synthetic genetic constructs |
| 11/27/2008 | WO2008121802A3 Lipoprotein lipase and its effect on statin treatments |
| 11/27/2008 | WO2008121788A3 Haplotypes of lipoprotein lipase, visceral adiposity and fasting insulin levels |
| 11/27/2008 | WO2008118998A3 Method for multiplex detection and quantitation of nucleic acids |
| 11/27/2008 | WO2008118258A8 Genemap of the human genes associated with adhd |
| 11/27/2008 | WO2008115415A3 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 11/27/2008 | WO2008115054A3 A method for regulating eukaryotic gene expression at the level of chromatin |
| 11/27/2008 | WO2008113017A3 Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule |
| 11/27/2008 | WO2008112772A3 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 11/27/2008 | WO2008112703A3 Compositions and methods for diagnosing and treating diabetic micro vascular complications |
| 11/27/2008 | WO2008107377A3 Combinations of markers for sepsis risk assessment |
| 11/27/2008 | WO2008106115A3 Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy |
| 11/27/2008 | WO2008105764A3 Breast milk contaminant detection device |
| 11/27/2008 | WO2008104287A3 Tnnt2 as a biomarker for ppara modulators |
| 11/27/2008 | WO2008103702A3 Methods and compositions for rapid light-activated isolation and detection of analytes |
| 11/27/2008 | WO2008102002A3 New markers for cancer |
| 11/27/2008 | WO2008089397A3 Adrb2 cancer markers |
| 11/27/2008 | WO2008080082A3 Methods for modulating set and uses thereof |
| 11/27/2008 | WO2008079976A3 Dimeric high affinity egfr constructs and uses thereof |
| 11/27/2008 | WO2008076842A3 Sequencing methods |
| 11/27/2008 | WO2008070570A3 Positive selection of serum proteins for proteomic analysis |
| 11/27/2008 | WO2008070227A3 A method for the identification of human immunodeficiency virus related antibodies in blood |
| 11/27/2008 | WO2008070160A3 Cancer-linked genes as biomarkers to monitor response to impdh inhibitors |
| 11/27/2008 | WO2008069864A3 Mn/ca9 splice variants |
| 11/27/2008 | WO2008067195A3 Genemap of the human genes associated with crohn's disease |
| 11/27/2008 | WO2008066982A3 A method of surface plasmon resonance (spr) technology to detect genomic aberrations in patients with chronic lymphocytic leukemia |
| 11/27/2008 | WO2008066655A3 Assessment of oocyte competence |
| 11/27/2008 | WO2008063655A3 Dna methylation markers and methods of use |
| 11/27/2008 | WO2008063321A3 Gpr81-ligand complexes and their preparation and use |
| 11/27/2008 | WO2008046113A3 In vitro assay for bioactive follicle stimulating hormone |
| 11/27/2008 | WO2008045288A3 Method for a continuous rapid thermo cycle system |
| 11/27/2008 | WO2008039475A3 A gene expression profiling based identification of genomic signatures of multiple myeloma and uses thereof |
| 11/27/2008 | WO2008039445A3 Polymorphisms in the human xbp-1 gene are associated with inflammatory bowel disease |
| 11/27/2008 | WO2008036317A3 Systems and methods for pathogen detection and response |
| 11/27/2008 | WO2008030845A3 Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis |
| 11/27/2008 | WO2008030627A3 G-protein coupled receptor kinase-5 polymorphism |
| 11/27/2008 | WO2008016995A3 Methods of identifying modulators of insulin signalling |
| 11/27/2008 | WO2008016615A3 Methods for high sensitivity detection of genetic polymorphisms |
| 11/27/2008 | WO2008011284A3 Methods and compositions for repression of occludin |
| 11/27/2008 | WO2008010085A3 Prognostic method |
| 11/27/2008 | WO2008008484A3 Detection of truncation mutations by mass spectrometry |
| 11/27/2008 | WO2008008336A3 Chemo-selective identification of therapeutics |
| 11/27/2008 | WO2008005361A3 Embedded data dna sequence security system |
| 11/27/2008 | WO2008002680A3 A method of modifying a macromolecule without prior extraction from a sample |
| 11/27/2008 | WO2007149791A3 System for isolating biomolecules from a sample |
| 11/27/2008 | WO2007147110A3 Controlled initiation of primer extension |
| 11/27/2008 | WO2007143183A3 Methods for developing and assessing therapeutic agents |
| 11/27/2008 | WO2007142840A3 Corn event mir162 |
| 11/27/2008 | WO2007140251A3 Apparatus and method for performing mass spectroscopy |
| 11/27/2008 | WO2007140015A3 Biochemical analysis of partitioned cells |
| 11/27/2008 | WO2007136874A3 Genomic library construction |
| 11/27/2008 | WO2007136782A3 Kits and methods for evaluating misfolded proteins |
| 11/27/2008 | WO2007133682A3 100% sequence identity detection methods for variable genomes |
| 11/27/2008 | WO2007118073A3 Obesity and body fat distribution |
| 11/27/2008 | WO2007117642A3 Neisseria gonorrhoeae specific oligonucleotide sequences |
| 11/27/2008 | WO2007117589A3 Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis |
| 11/27/2008 | WO2007109324A3 Potent and selective nav 1.7 sodium channel blockers |
| 11/27/2008 | WO2007104062A3 Compositions and methods based on peptide binding profiling |
| 11/27/2008 | WO2007103374A3 Toxicity screening methods |
| 11/27/2008 | WO2007101075A3 Double-ligation method for haplotype and large-scale polymorphism detection |
| 11/27/2008 | WO2007100875A3 Nac-i as a prognostic marker and a target for therapeutic target in human cancer |
| 11/27/2008 | WO2007098326A3 Method for screening hiv drug sensitivity |
| 11/27/2008 | WO2007098065A3 Human sodium channel isoforms |
| 11/27/2008 | WO2007095464A3 Signal amplification of biorecognition events using photopolymerization in the presence of air |
| 11/27/2008 | WO2007095055A3 Methods and compositions for detecting viral nucleic acid in a cell |
| 11/27/2008 | WO2007092279A3 Detection of contaminating dna via amplification of sequences of less than 100 bp |
| 11/27/2008 | WO2007087612A8 Detection and diagnosis of smoking related cancers |
| 11/27/2008 | WO2007084902A3 Methods of determining relative genetic likelihoods of an individual matching a population |
| 11/27/2008 | WO2007081385A8 Microfluidic devices and methods of use in the formation and control of nanoreactors |
| 11/27/2008 | WO2007047924A3 Improved target ligand detection |
| 11/27/2008 | WO2007016680A3 Phage-display plant defense peptides directed against phakopsora pachyrhizi and uromyces appendiculatus |
| 11/27/2008 | WO2007010219A3 Methods for modulating a wnk i soform protein kinase activity |
| 11/27/2008 | WO2006138445A3 Methods and substrates for conducting assays |
| 11/27/2008 | WO2006127562A3 Wireless power transmission system |
| 11/27/2008 | WO2006118986A3 Customized and dynamic association of probe type with feature extraction algorithms |
| 11/27/2008 | WO2006091470A3 Improved halohydrin dehalogenases and related polynucleotides |
| 11/27/2008 | WO2006086761A3 Methods of identifying genes which modulate myelination |
| 11/27/2008 | WO2006050046A3 Dre recombinase and recombinase systems employing dre recombinase |
| 11/27/2008 | WO2005030981A3 Homogeneous populations of molecules |
| 11/27/2008 | WO2004112726A3 Methods and compositions for controlling appetite and modulating insulin sensitivity |
| 11/27/2008 | US20080295197 Stimulating root growth; point mutations |